Chemistry:Parsaclisib
From HandWiki
Parsaclisib is an investigational drug that it being evaluated for the treatment of B-cell malignancies. It is a PI3Kδ (phosphoinositide 3-kinase) inhibitor.[1][2]
References
- ↑ "Targeting the PI3K pathway in myeloproliferative neoplasms". Expert Review of Anticancer Therapy 22 (8): 835–843. August 2022. doi:10.1080/14737140.2022.2093192. PMID 35763287.
- ↑ "Parsaclisib - Incyte Corporation". AdisInsight. Springer Nature Switzerland AG. https://adisinsight.springer.com/drugs/800039479.
 |  |
